Skip to search formSkip to main contentSkip to account menu

TCH 346

Known as: TCH-346, TCH346 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
280 TCH346 Targets Mitochondria and Protects in Combined Ethanol and Acetaminophen Mouse Liver Injury Independently of GAPDH
2007
2007
Negative treatment trials on Huntington’s disease, ALS and stroke
Why is it important to also publish negative trials? First, patients should not be treated with ineffective, potentially harmful… 
2007
2007
No evidence of a neuroprotective effect for TCH346 in Parkinson's disease
gene encoding the human form of GTP cyclohydrolase—was significantly associated with low scores for leg pain following diskec… 
2004
2004
Simultaneous analytical method for the determination of TCH346 and its four metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
TCH346 (dibenzo[b,f]oxepin-10-ylmethyl-prop-2-ynylamine) is a novel propargylamine compound under investigation as a putative… 
2003
2003
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)